ZNF583 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.695500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.497000E-01
Normal-vs-Stage2
3.470400E-02
Normal-vs-Stage3
2.251800E-02
Normal-vs-Stage4
9.083800E-01
Stage1-vs-Stage2
1.861820E-01
Stage1-vs-Stage3
1.342450E-01
Stage1-vs-Stage4
7.707800E-01
Stage2-vs-Stage3
3.774200E-01
Stage2-vs-Stage4
9.635700E-03
Stage3-vs-Stage4
6.253700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.006100E-02
Normal-vs-AfricanAmerican
5.479600E-01
Normal-vs-Asian
2.574400E-02
Caucasian-vs-AfricanAmerican
2.834800E-01
Caucasian-vs-Asian
4.468200E-01
AfricanAmerican-vs-Asian
2.035800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.553900E-02
Normal-vs-Female
1.229980E-01
Male-vs-Female
2.073600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.476400E-01
Normal-vs-Age(41-60Yrs)
1.931830E-01
Normal-vs-Age(61-80Yrs)
6.820200E-02
Normal-vs-Age(81-100Yrs)
1.696810E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.751630E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.769600E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.407600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.749200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.214400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.050400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.697900E-03
Normal-vs-Daily Drinker
9.104700E-03
Normal-vs-Weekly Drinker
7.858100E-02
Normal-vs-Occasional Drinker
6.196200E-02
Normal-vs-Social Drinker
3.902800E-01
Non Drinker-vs-Daily Drinker
9.117600E-01
Non Drinker-vs-Weekly Drinker
1.039200E-01
Non Drinker-vs-Occasional Drinker
1.875810E-01
Non Drinker-vs-Social Drinker
7.018500E-02
Daily Drinker-vs-Weekly Drinker
1.159370E-01
Daily Drinker-vs-Occasional Drinker
1.979840E-01
Daily Drinker-vs-Social Drinker
4.481700E-02
Weekly Drinker-vs-Occasional Drinker
7.432800E-01
Weekly Drinker-vs-Social Drinker
5.160600E-01
Occasional Drinker-vs-Social Drinker
3.395000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.744200E-01
Normal-vs-Grade 2
2.089800E-01
Normal-vs-Grade 3
3.391400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.239000E-01
Grade 1-vs-Grade 3
1.124000E-01
Grade 1-vs-Grade 4
2.744200E-01
Grade 2-vs-Grade 3
2.509200E-01
Grade 2-vs-Grade 4
2.089800E-01
Grade 3-vs-Grade 4
3.391400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.160400E-02
Normal-vs-NonDiabetic
7.560200E-02
Diabetic-vs-NonDiabetic
8.362200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.456570E-03
Normal-vs-NoPancreatitis
9.232400E-02
Pancreatitis-vs-NoPancreatitis
2.576200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.902630E-01
Normal-vs-N1
4.986400E-02
N0-vs-N1
4.549800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.357800E-03
Normal-vs-TP53-NonMutant
3.660800E-01
TP53-Mutant-vs-TP53-NonMutant
6.404100E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
